By directly modifying genes inside the body, CRISPR therapies could revolutionize treatment across many medical disciplines. Conditions caused by a single gene such as sickle cell anemia, cystic fibrosis and Tay-Sachs disease are prime targets for CRISPR intervention. Additionally, inherited cancers may be prevented by edits that render genes associated with tumor growth nonfunctional. The global CRISPR genomic cure market is estimated to be valued at US$ 4.62 Bn in 2024 and is expected to exhibit a CAGR of 20.% over the forecast period 2024 to 2031.
Get More Insights On CRISPR Genomic Cure Market
https://www.insightprobing.com..../crispr-genomic-cure
Like
Comment
Share
